Patrick Trucchio Analyst PerformanceManaging Director of Equity Research at HC WainwrightPatrick Trucchio is a stock analyst at HC Wainwright in the medical sector, covering 33 publicly traded companies. Over the past year, Patrick Trucchio has issued 76 stock ratings, including and buy recommendations. While full access to Patrick Trucchio's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Patrick Trucchio's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Ratings, Coverage, and Performance StatisticsAnalyst RatingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings142 Last 6 YearsBuy Recommendations96.40% 134 Buy RatingsCompanies Covered33 Unique Companies Ratings Distribution139RatingsDistribution of strong buy, buy, hold, and sell ratings by Patrick Trucchio.RatingPercentageCount Strong Buy0.0%0 ratings Buy96.4%134 ratings Hold2.9%4 ratings Sell0.7%1 ratingsOut of 139 total stock ratings issued by Patrick Trucchio at HC Wainwright, the majority (96.4%) have been Buy recommendations, followed by 2.9% Hold and 0.7% Sell.Best & Worst CallsBest Call0000.0%FSTXMar 2022Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%DTILOct 2021Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ75.8% of companies on NASDAQ25 companiesNYSE12.1% of companies on NYSE4 companiesTSE6.1% of companies on TSE2 companiesOTCMKTS3.0% of companies on OTCMKTS1 companyOTC3.0% of companies on OTC1 companyPatrick Trucchio, an analyst at HC Wainwright, currently covers 33 companies listed on NASDAQ, NYSE, TSE, OTCMKTS and OTC, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical33 companies100.0%Patrick Trucchio of HC Wainwright specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE16 companies48.5%PHARMACEUTICAL PREPARATIONS6 companies18.2%MED - DRUGS3 companies9.1%BIOTECHNOLOGY3 companies9.1%MED - GENERIC DRG1 company3.0%MEDICAL SERVICES1 company3.0%MED - OUTP/HM CRE1 company3.0%OUTPATIENT MENTAL HEALTH & SUBSTANCE ABUSE CENTERS1 company3.0%MED PRODUCTS1 company3.0% About Patrick TrucchioMr. Trucchio is a Managing Director of Equity Research at H.C. Wainwright whose research focuses on biotechnology, specifically on inflammation, fibrosis, cardio-metabolic, CNS, and rare diseases in addition to other areas. Mr. Trucchio has thirteen years of research experience on the sell-side. Prior to joining H.C. Wainwright, Mr. Trucchio was a senior equity research analyst at Berenberg Capital Markets (BCM) covering biotechnology and specialty pharmaceutical companies. Prior to Berenberg Capital Markets, Mr. Trucchio worked at Wells Fargo Securities and BMO Capital Markets. At Wells Fargo, Mr Trucchio worked on an Institutional Investor ranked analyst team covering specialty pharmaceutical companies. Mr. Trucchio’s educational background includes an M.B.A. with Honors from St. John’s University and a B.S. in Finance from The Pennsylvania State University.Follow on LinkedIn Patrick Trucchio's Ratings History at HC Wainwright Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export to Excel CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsASMBAssembly Biosciences8/18/2025Initiated Coverage$25.44$50.00Buy$0.0000.00% ROIALTAltimmune8/13/2025Reiterated Rating$3.85$12.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals8/7/2025Boost Price Target$428.14$570.00Buy$0.0000.00% ROICMPSCOMPASS Pathways8/4/2025Lower Price Target$4.73$40.00Buy$0.0000.00% ROIATAIatai Life Sciences7/30/2025Reiterated Rating$3.49$15.00Buy$0.0000.00% ROICMPSCOMPASS Pathways7/15/2025Reiterated Rating$3.64$45.00Buy$0.0000.00% ROIALTAltimmune6/27/2025Reiterated Rating$3.61$12.00Buy$0.0000.00% ROIIVVDInvivyd6/26/2025Reiterated Rating$0.77$5.00Buy$0.0000.00% ROISGMOSangamo Therapeutics6/24/2025Reiterated Rating$0.50$10.00Buy$0.0000.00% ROISLNSilence Therapeutics6/13/2025Reiterated Rating$5.59$75.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. IMCRImmunocore6/2/2025Reiterated Rating$38.51$100.00Buy$0.0000.00% ROIQUREuniQure5/29/2025Reiterated Rating$15.33$70.00Buy$0.0000.00% ROIIVVDInvivyd5/28/2025Lower Price Target$0.88$5.00Buy$0.0000.00% ROIONCYOncolytics Biotech5/21/2025Reiterated Rating$0.43$5.00Buy$0.0000.00% ROIDTILPrecision BioSciences5/21/2025Reiterated Rating$4.88$60.00Buy$0.0000.00% ROIATAIatai Life Sciences5/20/2025Reiterated Rating$1.84$10.00Buy$0.0000.00% ROIARWRArrowhead Pharmaceuticals5/20/2025Reiterated Rating$15.74$80.00Buy$0.0000.00% ROICMPSCOMPASS Pathways5/12/2025Reiterated Rating$3.79$45.00Buy$0.0000.00% ROIGHRSGH Research5/9/2025Reiterated Rating$10.94$40.00Buy$0.0000.00% ROIQUREuniQure4/21/2025Reiterated Rating$13.72$70.00Buy$0.0000.00% ROIVYGRVoyager Therapeutics4/8/2025Reiterated Rating$2.93$30.00Buy$0.0000.00% ROIBEAMBeam Therapeutics4/7/2025Reiterated Rating$15.27$80.00Buy$0.0000.00% ROISGMOSangamo Therapeutics4/7/2025Reiterated Rating$0.66$10.00Buy$0.0000.00% ROIANROAlto Neuroscience4/7/2025Initiated Coverage$1.87$10.00Buy$0.0000.00% ROIALTAltimmune4/3/2025Reiterated Rating$4.61$12.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals4/2/2025Reiterated Rating$261.73$500.00Buy$0.0000.00% ROIDTILPrecision BioSciences3/28/2025Reiterated Rating$4.54$60.00Buy$0.0000.00% ROIMISTMilestone Pharmaceuticals3/28/2025Reiterated Rating$0.95$25.00Buy$0.0000.00% ROIIVVDInvivyd3/26/2025Reiterated Rating$0.66$10.00Buy$0.0000.00% ROIATAIatai Life Sciences3/19/2025Reiterated Rating$1.38$10.00Buy$0.0000.00% ROIDTILPrecision BioSciences3/19/2025Reiterated Rating$4.91$60.00Buy$0.0000.00% ROIGOSSGossamer Bio3/18/2025Reiterated Rating$1.39$10.00Buy$0.0000.00% ROIALTAltimmune3/18/2025Reiterated Rating$5.97$12.00Buy$0.0000.00% ROIMISTMilestone Pharmaceuticals3/17/2025Reiterated Rating$2.45$25.00Buy$0.0000.00% ROIVYGRVoyager Therapeutics3/13/2025Reiterated Rating$4.06$30.00Buy$0.0000.00% ROIIMCRImmunocore3/12/2025Reiterated Rating$28.42$100.00Buy$0.0000.00% ROIBEAMBeam Therapeutics3/10/2025Reiterated Rating$24.32$80.00Buy$0.0000.00% ROIONCYOncolytics Biotech3/10/2025Reiterated Rating$0.66$5.00Buy$0.0000.00% ROIMNMDMind Medicine (MindMed)3/7/2025Reiterated Rating$6.61$55.00Buy$0.0000.00% ROISLNSilence Therapeutics3/7/2025Reiterated Rating$4.74$75.00Buy$0.0000.00% ROICMPSCOMPASS Pathways3/4/2025Reiterated Rating$3.75$45.00Buy$0.0000.00% ROIQUREuniQure3/4/2025Reiterated Rating$10.76$70.00Buy$0.0000.00% ROIVYGRVoyager Therapeutics3/3/2025Reiterated Rating$4.00$30.00Buy$0.0000.00% ROIALTAltimmune3/3/2025Reiterated Rating$6.24$12.00Buy$0.0000.00% ROIBEAMBeam Therapeutics2/28/2025Reiterated Rating$27.27$80.00Buy$0.0000.00% ROIMISTMilestone Pharmaceuticals2/28/2025Reiterated Rating$1.75$25.00Buy$0.0000.00% ROIVIRVir Biotechnology2/28/2025Reiterated Rating$8.01$110.00Buy$0.0000.00% ROIIMCRImmunocore2/28/2025Reiterated Rating$29.13$100.00Buy$0.0000.00% ROIIVVDInvivyd2/24/2025Reiterated Rating$1.43$10.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals2/24/2025Boost Price Target$252.00$500.00Buy$0.0000.00% ROIDTILPrecision BioSciences2/19/2025Reiterated Rating$5.63$60.00Buy$0.0000.00% ROIATAIatai Life Sciences2/13/2025Reiterated Rating$2.55$10.00Buy$0.0000.00% ROICYBNCybin2/13/2025Lower Price Target$9.36$150.00Buy$0.0000.00% ROICMPSCOMPASS Pathways2/13/2025Lower Price Target$4.25$45.00Buy$0.0000.00% ROIARWRArrowhead Pharmaceuticals2/12/2025Reiterated Rating$18.57$80.00Buy$0.0000.00% ROIALTAltimmune2/5/2025Reiterated Rating$6.88$12.00Buy$0.0000.00% ROIIVVDInvivyd2/4/2025Reiterated Rating$1.06$10.00Buy$0.0000.00% ROIBEAMBeam Therapeutics2/3/2025Reiterated Rating$25.92$80.00Buy$0.0000.00% ROIONCYOncolytics Biotech2/3/2025Reiterated Rating$0.73$5.00Buy$0.0000.00% ROIVIRVir Biotechnology1/31/2025Reiterated Rating$10.31$110.00Buy$0.0000.00% ROIMNMDMind Medicine (MindMed)1/31/2025Reiterated Rating$7.13$55.00Buy$0.0000.00% ROIGOSSGossamer Bio1/30/2025Reiterated Rating$0.92$10.00Buy$0.0000.00% ROISLNSilence Therapeutics1/29/2025Reiterated Rating$5.28$75.00Buy$0.0000.00% ROIATAIatai Life Sciences1/28/2025Reiterated Rating$1.42$10.00Buy$0.0000.00% ROICYBNCybin1/27/2025Reiterated Rating$9.46$190.00Buy$0.0000.00% ROIVYGRVoyager Therapeutics1/27/2025Reiterated Rating$5.62$30.00Buy$0.0000.00% ROIQUREuniQure1/27/2025Boost Price Target$15.67$70.00Buy$0.0000.00% ROIGHRSGH Research1/27/2025Reiterated Rating$8.83$40.00Buy$0.0000.00% ROIIMCRImmunocore1/27/2025Reiterated Rating$33.00$100.00Buy$0.0000.00% ROISGMOSangamo Therapeutics1/27/2025Reiterated Rating$1.16$10.00Buy$0.0000.00% ROIMISTMilestone Pharmaceuticals1/27/2025Reiterated Rating$2.05$25.00Buy$0.0000.00% ROIARWRArrowhead Pharmaceuticals1/23/2025Reiterated Rating$19.71$80.00Buy$0.0000.00% ROIALTAltimmune1/22/2025Reiterated Rating$6.94$12.00Buy$0.0000.00% ROIALNYAlnylam Pharmaceuticals1/13/2025Reiterated Rating$249.59$400.00Buy$0.0000.00% ROIDTILPrecision BioSciences1/10/2025Reiterated Rating$4.50$60.00Buy$0.0000.00% ROIGHRSGH Research1/10/2025Reiterated Rating$8.40$40.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.